Bismuth Citrate, a compound with the CAS number 813-93-4, is recognized for its significant utility within the pharmaceutical sector, particularly in formulations designed to address common and severe digestive tract conditions. As a manufacturer and supplier based in China, NINGBO INNO PHARMCHEM CO.,LTD. plays a crucial role in making this compound available to drug developers and manufacturers worldwide. Our commitment is to provide a consistent and high-quality supply of Bismuth Citrate, essential for producing effective treatments for a range of gastrointestinal ailments.

The therapeutic applications of Bismuth Citrate are diverse, primarily revolving around its use as an intermediate in the production of stomachache remedies and anti-ulcer medications. Its specific utility extends to treating conditions such as gastric ulcers, duodenal ulcers, compound ulcers, and stoma ulcers. Furthermore, it is integral to therapies aimed at managing chronic superficial gastritis, especially when this condition is exacerbated by Helicobacter pylori (H. pylori) infections. The presence of bismuth in these formulations is often linked to its ability to coat and protect the stomach lining, as well as its antimicrobial properties against certain bacteria.

For pharmaceutical companies focusing on gastrointestinal health, sourcing reliable Bismuth Citrate is a critical step. NINGBO INNO PHARMCHEM CO.,LTD. offers Bismuth Citrate with a guaranteed assay of 49%-54%, ensuring that the chemical integrity required for drug efficacy is maintained. We understand that for treatments targeting conditions like gastric ulcers, the precise formulation and active ingredient quality are non-negotiable. Our role as a supplier is to ensure that these standards are met consistently, allowing our clients to focus on their core manufacturing and development processes.

The market for Bismuth Citrate for stomachache drugs and other gastrointestinal treatments is substantial. By providing a crucial building block for these medications, we contribute to improving public health outcomes. Our capabilities as a producer in China, with an annual capacity of 300MT, enable us to support both large-scale manufacturing projects and specialized drug development initiatives. Whether you are seeking an intermediate for new drug discovery or a stable supplier for existing product lines, our Bismuth Citrate CAS 813-93-4 is an excellent choice.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to being more than just a supplier; we aim to be a partner in your pharmaceutical endeavors. Our expertise in producing intermediates like Bismuth Citrate for anti-ulcer drug synthesis means we understand the regulatory and quality demands of the industry. We are confident that our product can facilitate the creation of potent and safe medications for patients suffering from digestive disorders.

If your research or production involves treating H. pylori infections or developing new remedies for digestive discomfort, consider the role Bismuth Citrate can play. As a leading supplier in China, NINGBO INNO PHARMCHEM CO.,LTD. is ready to meet your needs for high-quality Bismuth Citrate, ensuring your final products contribute effectively to patient well-being.